XML 60 R51.htm IDEA: XBRL DOCUMENT v3.25.3
Operating Segments - Schedule of Group’s CODM (Details) - USD ($)
$ in Thousands
 6 Months Ended 12 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Schedule of Group’s CODM [Line Items]      
Total revenues $ 461 $ 840 $ 1,306
Segment loss (gain) 2,713 3,527 7,316
Equity losses from the investment in MitoCareX 312 208 429
Finance expense (income), net 414 (51) (259)
Loss on impairment of loans 5,973
Tax income (5) (14)
Loss 9,412 3,679 7,472
Segment Assets 5,139   10,171
Segment Liabilities 5,220   1,420
Drug Development [Member]      
Schedule of Group’s CODM [Line Items]      
Total revenues
Segment loss (gain) 2,543 3,040 4,873
Segment Assets 3,497   8,407
Segment Liabilities 5,033   1,194
Online Sales [Member]      
Schedule of Group’s CODM [Line Items]      
Total revenues 461 840 1,306
Segment loss (gain) 170 487 2,443
Segment Assets 1,642   1,764
Segment Liabilities 187   226
External [Member]      
Schedule of Group’s CODM [Line Items]      
Total revenues 461 840 1,306
External [Member] | Drug Development [Member]      
Schedule of Group’s CODM [Line Items]      
Total revenues
External [Member] | Online Sales [Member]      
Schedule of Group’s CODM [Line Items]      
Total revenues $ 461 $ 840 $ 1,306